Is Warren Buffett's $9.7 Billion Acquisition of OxyChem an Act of Brilliance or a Big Mistake for Berkshire Hathaway Investors?
Berkshire’s OxyChem acquisition could be Buffett’s last deal before he passes the torch to Greg Abel in a few months.
On Jan. 1, 2026, Warren Buffett will step down as chief executive officer (but remain chairman) of Berkshire Hathaway (BRK.A 0.00%) (BRK.B 0.33%) —